Aflac Incorporated logo AFL - Aflac Incorporated

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 9
HOLD 18
SELL 5
STRONG
SELL
0
| PRICE TARGET: $116.33 DETAILS
HIGH: $130.00
LOW: $99.00
MEDIAN: $118.00
CONSENSUS: $116.33
DOWNSIDE: 4.58%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Mild
Trading 14.4% below fair value
Current Price $121.91
Bear Case $96.52 20.8% downside ($96.52 - $121.91) / $121.91 = -20.8% ROTCE 13.4% → 2.59x TBV
Fair Value $142.43 16.8% upside ($142.43 - $121.91) / $121.91 = 16.8% ROTCE 17.8% → 3.82x TBV
Bull Case $149.05 22.3% upside ($149.05 - $121.91) / $121.91 = 22.3% ROTCE 20.5% → 4.00x TBV

Adjust Assumptions

17.8%
7.6%

Key Value Driver

ROTCE (17.8%) vs. cost of equity (7.6%)

Implied Market Multiple 3.03x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $116.33 from 32 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $142.43 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $116.33 (from 32 analysts). Our estimate is 32% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly